Please try another search
PetMed Express, Inc. (NASDAQ:PETS) is a pet pharmacy company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is...
JinkoSolar Holding Co., Ltd. (NYSE:JKS) reported first-quarter 2017 adjusted earnings per American Depositary Share (ADS) of 28 cents that missed the Zacks Consensus Estimate of 48 cents by 41.7%....
Cheniere Energy, Inc. (NYSE:LNG) has attained major regulatory and financial milestones with respect to the development of its earlier announced interstate natural gas pipeline operation -- Midship...
Heliad Equity Partners KGAA (DE:HPBGn) is a DACH-focused investor in the tech, e-commerce and lifestyle sectors. It is managed by Heliad Management GmbH, a company wholly owned by Heliad’s...
European Investment Trust Plc(The) (LON:EUTP) aims to generate long-term capital growth from a diversified portfolio of European equities. Since August 2016, EUT has been managed by Craig Armour, who...
Caseys General Stores Inc (NASDAQ:CASY)Casey’s General Stores, Inc. (CASY), a national company that operates convenience stores yesterday reported their fourth quarter fiscal 2017 financial...
Welcome to Episode #85 of the Zacks Market Edge Podcast. Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds...
Novartis AG (NYSE:NVS) announced that it has entered into clinical research collaboration with Bristol-Myers Squibb Company (NYSE:BMY) .Per the terms of the agreement, Bristol-Myers will...
Seattle Genetics, Inc. (NASDAQ:SGEN) and Astellas announced positive phase I results for pipeline candidate enfortumab vedotin (ASG-22ME). The candidate was assessed as monotherapy treatment for...
McCormick & Company, Incorporated (NYSE:MKC) looks promising supported by its portfolio, robust initiatives and impressive earnings history.Shares of this Zacks Rank #2 (Buy) company have...
Shares of Sysco Corporation (NYSE:SYY) have exhibited a bullish run over the last one year. This Zacks Rank #3 (Hold) stock was up 13.9% against the Zacks categorized...
Kite Pharma, Inc. (NASDAQ:KITE) announced results from phase I trial, ZUMA-3, on lead candidateKTE-C19 (axicabtagene ciloleucel) in adults with high burden relapsed/refractory acute lymphoblastic...
Norfolk Southern Corporation (NYSE:NSC) had an impressive first-quarter 2017, reporting better-than-expected earnings and revenues. Both metrics also improved on a year-over-year basis. Volume...
The airline industry received encouraging news when the International Air Transport Association (IATA) increased its projection for 2017 global net profit for the industry by 5.4% to $31.4 billion. At...
Merck & Co., Inc. (NYSE:MRK) announced positive data from a phase III study KEYNOTE-024, evaluating its anti-PD-1 therapy, Keytruda (pembrolizumab) for first-line treatment of patients with...